China’s Experimental Covid Vaccine Helps North Korea’s Kim Family Take a Dose of Hope
In a twist that feels straight out of a political thriller, China’s super‑experimental coronavirus vaccine has found its way into the hands—and needles—of Kim Jong‑Un and his clan.
Who’s in the Shot?
- Kim Jong‑Un himself
- Any close family members (no names shared publicly)
- Several top North Korean officials
Sources say the Kims only received the shot in the last two to three weeks, courtesy of a Chinese company that still has its safety credentials murky. Just as a movie plot can be thrilling, so can a vaccine’s uncertain track record.
The Chinese Vaccine Players
- Sinovac Biotech Ltd. – known for its existing in‑house shots, but no solid Phase 3 data.
- CanSinoBio. – also under the “experimental” label.
- Sinophram Group. – claims a candidate has already been tried on nearly one million Chinese citizens.
None of these firms have stepped up a public Phase 3 trial, leaving questions about efficacy and safety as unanswered as the pajama size for a toddler.
Did North Korea Get Any Covid Cases Yet?
Officially, the country hasn’t confirmed any COVID infections. However, South Korea’s National Intelligence Service warns that an outbreak is still possible, given past trade and people exchanges with China before the borders were shut in January.
Meanwhile, the Digital Battlefield
Microsoft recently reported that two North Korean hacking crews had targeted several vaccine developers across the globe—including a British drugmaker named AstraZeneca. The South Korean intelligence agency said they had stopped these attacks. So, while the Kims received their physical shots, the digital world remains in a constant state of warding off cyber‑threats.
TL;DR
China gave Kim Jong‑Un’s family a prototype Covid vaccine, but which company’s product, and whether it’s safe, remains a mystery. No confirmed North Korean Covid cases yet, but experts say vigilance is still due.
